The current PE ratio of DBD cannot be calculated, as the latest EPS of -$0.44 is negative. Diebold Nixdorf's last PE ratio on record was 4466.0 in September 2024.
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | N/A | N/A | $43.04 | -$0.44 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Dec 2024 | N/A | N/A | $43.04 | -$0.44 |
Sep 2024 | 4,466 | N/A | $44.66 | $0.01 |
Jun 2024 | N/A | N/A | $38.48 | N/A |
Mar 2024 | N/A | N/A | $34.44 | N/A |
Dec 2023 | N/A | N/A | $28.95 | N/A |
Sep 2023 | N/A | N/A | $18.94 | N/A |
Jun 2023 | N/A | N/A | N/A | N/A |
Dec 2022 | N/A | N/A | N/A | N/A |
Jun 2022 | N/A | N/A | N/A | N/A |
Stock name | PE ratio | Market cap |
---|---|---|
ADT ADT Inc | 14.96 | $7.35B |
BCO Brinks Co | 24.66 | $3.91B |
PAY Paymentus Holdings Inc | 76.42 | $3.44B |
PBI Pitney Bowes Inc | N/A | $1.67B |
PAR Par Technology Corp | N/A | $2.46B |
DBD Diebold Nixdorf Inc | N/A | $1.68B |
The current price to earnings ratio of DBD cannot be determined, as its EPS of -$0.44 is negative.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.